Symbol="SRPT"
AssetType="Common Stock"
Name="Sarepta Therapeutics Inc"
Description="Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="873303"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="10422408000"
EBITDA="-460492000"
PERatio="None"
PEGRatio="159.25"
BookValue="7.95"
DividendPerShare="0"
DividendYield="0"
EPS="-12.66"
RevenuePerShareTTM="11.39"
ProfitMargin="-0.905"
OperatingMarginTTM="-0.502"
ReturnOnAssetsTTM="-0.103"
ReturnOnEquityTTM="-1.237"
RevenueTTM="1003434000"
GrossProfitTTM="-78066000"
DilutedEPSTTM="-12.66"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.119"
AnalystTargetPrice="176.94"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="12.49"
PriceToBookRatio="25.74"
EVToRevenue="12.09"
EVToEBITDA="-17.47"
Beta="0.979"
num_52WeekHigh="159.89"
num_52WeekLow="100.15"
num_50DayMovingAverage="112.72"
num_200DayMovingAverage="123.18"
SharesOutstanding="93149000"
DividendDate="None"
ExDividendDate="None"
symbol="SRPT"
open="108.80"
high="112.13"
low="108.01"
price="111.89"
volume="1219474.00"
latest_trading_day="2023-08-18"
previous_close="110.92"
change="0.97"
change_percent="0.8745%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="46"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="54"
Volume_recent_avg="1332519"
Change_recent_avg="-0.3"
Delta_recent_avg="4.01"
Variance_recent_avg="2.0"
Change_ratio_recent_avg="-0.26"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="54"
Aroon_momentum_negative="46"
image_negative_thumbnail_id_1="1158"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0192.jpeg"
image_negative_thumbnail_id_2="1156"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0190.jpeg"
image_neutral_thumbnail_id_1="521"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_neutral_thumbnail_id_2="583"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_positive_thumbnail_id_1="633"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0075.jpeg"
image_positive_thumbnail_id_2="631"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0077.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
